Tools
Stock profile

CENTENE CORP (CNC)

CNC · Latest close $67.45 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$67.45
As of Nov 18, 2026
Tracked funds holding
5 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
4
vs previous quarter

CENTENE CORP (CNC) is held by 5 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 4 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $3.8M sold). Latest close $67.45 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Aug 26, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-3.8M
Fundamentals
Revenue · FY2025
Red flags
screens flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Deerfield Management · Greenlight Capital · Lyrical Asset Management — 5 tracked funds hold CNC. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 1 sale ($3.8M). Insider trading

Often held alongside

CNH Industrial N.V. (CNH) · Envista Holdings Corp (NVST) · Cigna Group (CI) · COMCAST CORP (CMCSA) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Deerfield Management3.28%4,901,000TRIMMED (-17.2%) Q3 filed Nov 16
Greenlight Capital2.71%1,651,150TRIMMED (-39.6%) Q3 filed Nov 16
Lyrical Asset Management1.99%2,449,957TRIMMED (-3.3%) Q3 filed Nov 13
Oakmark Funds0.95%11,124,640TRIMMED (-21.1%) Q3 filed Nov 16
Tweedy Browne0.12%25,121ADDED (+32.5%) Q3 filed Nov 4

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +6.1% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

76.0123.182024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding1,005 of 8,857 filers
Long-only filers among them1,000
Change vs 2026 Q1+152 net · 905 entered · 753 exited
Shares reported, all filers480,787,408
Reported value, all filers$30.6B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryHospital & Medical Service Plans (SIC 6324)
Revenue · FY2025$194.8B
Net income · FY2025$-6.7B
Total assets · FY2025$76.7B
Shares outstanding495,068,000
Market cap (at latest close)$33.4B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 23, 2026.

Short interest

Shares short · Oct 15, 202610,934,979
Share of shares outstanding2.21%
Days to cover2.53

Shares short at recent settlements — Jul 31, 2026: 13.6M · Aug 14, 2026: 13.3M · Aug 31, 2026: 13.4M · Sep 15, 2026: 14.1M · Sep 30, 2026: 10.5M · Oct 15, 2026: 10.9M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 23, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 5K · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 276 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 23, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 1 sale by 1 insider ($3.8M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Aug 26, 2026KOSTER CHRISTOPHERSecretary & General CounselSell56,500$66.90$3.8MSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 26, 2026Burdick Kenneth AFormer Director43,600$2.8MAug 26, 2026SEC filing
Aug 26, 2026KOSTER CHRISTOPHEROfficer56,500$3.8MAug 26, 2026SEC filing
Aug 18, 2026KOSTER CHRISTOPHEROfficer47,603$3.1MAug 18, 2026SEC filing
Aug 5, 2026Burdick Kenneth AFormer Director100,000$6.8MAug 5, 2026SEC filing
Jun 10, 2026Burdick Kenneth ADirector80,000$5.2MJun 10, 2026SEC filing
Dec 4, 2025Burdick Kenneth ADirector32,796$1.3MDec 4, 2025SEC filing
Dec 3, 2025Burdick Kenneth ADirector33,211$1.3MDec 3, 2025SEC filing
Oct 15, 2025Wayne S DeVeydtDirector5,489$196.7KOct 15, 2025SEC filing
Sep 9, 2025DeVeydt Wayne SDirector10,775$314.5KSep 9, 2025SEC filing
Mar 21, 2025FASOLA KENNETH JOfficer8,500$502.0KMar 21, 2025SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Apr 29, 2026Vanguard Capital ManagementSC 13G35,946,9647.3%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 13, 2026AQR Capital Management, LLCSC 13G31,798,7386.5%Dec 31, 2025SEC filing
Nov 5, 2025FMR LLCSC 13G/A3,345,475.620.7%Sep 30, 2025SEC filing
Nov 4, 2025Norges BankSC 13G/A7,021,2851.4%Sep 30, 2025SEC filing
Aug 14, 2025HARRIS ASSOCIATES L PSC 13G/A20,418,7314.1%Jun 30, 2025SEC filing
Jul 16, 2025BlackRock, Inc.SC 13G/A38,215,4137.7%Jun 30, 2025SEC filing
May 12, 2025FMR LLCSC 13G26,577,525.175.4%Mar 31, 2025SEC filing
Feb 11, 2025Norges BankSC 13G25,444,8535.0%Dec 31, 2024SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Hospital & Medical Service Plans (SIC 6324). Standing committees with jurisdiction over this industry: House Committee on Financial Services, Senate Committee on Banking, Housing, and Urban Affairs.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 557 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Medicare/Medicaid (317), Health Issues (301), Insurance (17).

Federal contracts: $11.7B in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$3.2B
FY2022$3.6B
FY2023$3.6B
FY2024$1.0B
FY2025$51.1K
FY2026$194.1M

Largest awards collected

Award IDAgencyAmountStart
47QFCA19F0044General Services Administration$277.0MFeb 27, 2019
VA79116J0006Department of Veterans Affairs$265.0MOct 1, 2015
VA79117J0001Department of Veterans Affairs$254.3MOct 1, 2016
IND10PD18476Department of the Interior$250.4MAug 1, 2010
VA79118J0001Department of Veterans Affairs$114.2MOct 1, 2017

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Red Flags

· Distress Risk (Altman Z″) — Altman Z″-Score below 1.10

Key figures

· Growth — Latest revenue: $194.8B · 5-yr revenue CAGR: 11.9% · Straight growth years: 17

· Distress Risk (Altman Z″) — Z″-Score: 0.39 · Working capital / assets: 0.05 · Retained earnings / assets: 0.11 · EBIT / assets: -0.10 · Equity / liabilities: 0.35

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 3 of the last 20 quarterly lists; latest 2024 Q4, ranked #2 of 50.

· Politician BEST — appeared in 4 of the last 20 quarterly lists; latest 2025 Q3, ranked #16 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together250.0%-0.4%+4.8%-5.3%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold CNC — ranked by lift, the co-holding pattern described in Methodology: CNH Industrial N.V. (CNH) · Envista Holdings Corp (NVST) · Cigna Group (CI) · COMCAST CORP (CMCSA).

Recent 8-K filings

FiledItemsSource
Oct 27, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Oct 8, 20268.01 Other EventsSEC filing
Sep 16, 20267.01 Regulation FD DisclosureSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

CNH Industrial N.V. (CNH) · Track Record: how the signals scored · Practice timing on CNC

One email a week: the week’s new filings and research. Subscribe free

← CNA  ·  CNDT →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.